Efficacy and Safety of Tafolecimab in Chinese Patients With Non-Familial Hypercholesterolemia (CREDIT-1): A 48-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

被引：0
|
作者：
Huo, Yong
Li, Yong
Zhang, Ping
Deng, Huan
Li, Haoyu
An, Pei
Xue, Fengtai
Yu, Zhongxun
Ma, Qingyang
Qi, Litong
Chen, Beijian
Lian, Qiufang
Lu, Di
Qian, Lei
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10111
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of Juan Bi Pill with Add-on Methotrexate in Active Rheumatoid Arthritis: A 48-Week, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
    Jia, Qing-yun
    Wang, Yi-ru
    Sun, Da-wei
    Mao, Jian-chun
    Xue, Luan
    Gu, Xiao-hua
    Yu, Xiang
    Piao, Xue-mei
    Xu, Hao
    Liang, Qian-qian
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2025, 31 (02) : 99 - 107
  • [22] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
  • [23] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Zhang, Bo
    Cheng, Zhifeng
    Chen, Ji
    Zhang, Xin
    Liu, Dexue
    Jiang, Hongwei
    Ma, Guoqing
    Wang, Xiaoyun
    Gan, Shenglian
    Sun, Juan
    Jin, Ping
    Yi, Jianjun
    Shi, Bimin
    Ma, Jianhua
    Ye, Shandong
    Wang, Guixia
    Ji, Linong
    Gu, Xuejiang
    Yu, Ting
    An, Pei
    Deng, Huan
    Li, Haoyu
    Li, Li
    Ma, Qingyang
    Qian, Lei
    Yang, Wenying
    DIABETES CARE, 2024, 47 (01) : 160 - 168
  • [24] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [25] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [26] Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial
    Yiannakou, Yan
    Bouchoucha, Michel
    Schiefke, Ingolf
    Piessevaux, Hubert
    Filip, Rafal
    Stephenson, David
    Green, Alexandra
    Levine, Amy
    GASTROENTEROLOGY, 2014, 146 (05) : S160 - S160
  • [27] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [28] Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial
    Seol-Hee, Baek
    Je-Young, Shin
    Sung-Yeon, Sohn
    Kee, Hong Park
    Jun-Soon, Kim
    Bongjae, Kim
    So, Hyun Ahn
    Kyomin, Choi
    Yoon-Ho, Hong
    Sung, Jung-Joon
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 1 - 6
  • [29] A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever
    Koga, T.
    Sato, S.
    Hagimori, N.
    Yamamoto, H.
    Ishimura, M.
    Yasumi, T.
    Kirino, Y.
    Ikeda, K.
    Yachie, A.
    Migita, K.
    Kishida, D.
    Atsumi, T.
    Kawakami, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1535 - 1542
  • [30] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Deodhar, A.
    Van den Bosch, F.
    Poddubnyy, D.
    Maksymowych, W. P.
    Van der Heijde, D.
    Kim, T. H.
    Kishimoto, M.
    Duan, Y.
    Li, Y.
    Pangan, A.
    Wung, P.
    Song, I. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 9 - 10
12345